Pregabalin Completed Phase 3 Trials for Neuroses, Anxiety Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00150449Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.